Table 3. Cox Regression – Factors Associated with Survival.
Risk Factor | Hazard Ratio (95% CI) | p value |
---|---|---|
Treatment | ||
< 6 weeks | Reference | |
> 6 weeks | 1.15 (1.10–1.21) | <0.001 |
Age | ||
< 40 yo | 0.18 (0.14–0.22) | <0.001 |
40–49 | 0.19 (0.17–0.21) | <0.001 |
50–59 | 0.28 (0.26–0.30) | <0.001 |
60–69 | 0.47 (0.44–0.50) | <0.001 |
> 70 yo | Reference | |
Race/Ethnicity | ||
Non-Hispanic White | Reference | |
Non-Hispanic Black | 1.17 (1.08–1.27) | <0.001 |
Hispanic | 0.80 (0.71–0.90) | <0.001 |
Asian | 0.63 (0.52–0.76) | <0.001 |
Other/Unknown | 0.97 (0.83–1.14) | 0.712 |
Insurance Status | ||
Private Insurance | Reference | |
Medicaid/Uninsured | 1.40 (1.28–1.53) | <0.001 |
Income | ||
Lowest quartile | 1.14 (1.02–1.26) | 0.016 |
Second quartile | 1.09 (1.01–1.19) | 0.036 |
Third quartile | 1.07 (1.00–1.15) | 0.05 |
Fourth quartile | Reference | |
Unknown | 0.15 | 0.114 |
Education | ||
Lowest quartile | 1.16 (1.05–1.29) | 0.003 |
Second quartile | 1.07 (0.99–1.17) | 0.074 |
Third quartile | 1.08 (1.01–1.17) | 0.020 |
Fourth quartile | Reference | |
Unknown | 8.02 (0.75–85.4) | 0.084 |
CoMorbidity | ||
CDS 0 | Reference | |
CDS 1 | 1.37 (1.30–1.45) | <0.001 |
CDS 2 | 2.18 (1.97–2.41) | <0.001 |
AJCC Stage | ||
Stage 0 | 0.85 (0.05–0.14) | <0.001 |
Stage 1 | 0.11 (0.08–0.14) | <0.001 |
Stage 2 | 0.20 (0.15–0.26) | <0.001 |
Stage 3 | 0.30 (0.23–0.39) | <0.001 |
Stage 4 | Reference | |
Grade | ||
1 | Reference | |
2 | 1.48 (1.39–1.58) | <0.001 |
3 | 2.40 (2.24–2.57) | <0.001 |
Unknown | 2.15 (1.95–2.38) | <0.001 |
Nodes | ||
Negative | Reference | |
Positive | 1.38 (1.27–1.50) | <0.001 |
Not done | 1.50 (1.42–1.59) | <0.001 |
Unknown | 1.24 (0.89–1.73) | 0.195 |
Year of Treatment | ||
2003 | Reference | |
2004–2006 | 0.99 (0.94–1.04) | 0.646 |
2007–2009 | N/A | |
2010–2011 | N/A | |
Type of Endometrial Cancer | ||
Type I | 0.72 (0.68–0.76) | <0.001 |
Type II | Reference |